HCA Healthcare Q4 EPS Estimate Raised by Leerink Partnrs

HCA Healthcare, Inc. (NYSE:HCA) – Investment analysts at Leerink Partnrs increased their Q4 2025 earnings per share (EPS) estimates for HCA Healthcare in a research note issued on Sunday, July 27th. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings of $7.52 per share for the quarter, up from their prior forecast of $7.01. The consensus estimate for HCA Healthcare’s current full-year earnings is $24.98 per share. Leerink Partnrs also issued estimates for HCA Healthcare’s Q1 2026 earnings at $6.51 EPS, Q2 2026 earnings at $6.81 EPS, Q3 2026 earnings at $5.86 EPS, Q4 2026 earnings at $7.54 EPS, FY2026 earnings at $26.72 EPS, FY2027 earnings at $30.16 EPS and FY2028 earnings at $34.98 EPS.

A number of other equities research analysts also recently commented on HCA. Barclays dropped their price objective on HCA Healthcare from $416.00 to $390.00 and set an “overweight” rating for the company in a report on Monday. Baird R W downgraded HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 15th. Morgan Stanley lowered their price target on HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a report on Monday. Royal Bank Of Canada set a $401.00 price target on HCA Healthcare and gave the stock an “outperform” rating in a report on Monday. Finally, Guggenheim initiated coverage on HCA Healthcare in a report on Wednesday, April 9th. They issued a “neutral” rating for the company. Nine analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $396.46.

HCA Healthcare Trading Up 3.1%

NYSE HCA opened at $355.16 on Wednesday. The stock has a 50-day simple moving average of $371.51 and a 200 day simple moving average of $346.46. The company has a market capitalization of $85.44 billion, a PE ratio of 14.93, a P/E/G ratio of 1.08 and a beta of 1.47. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. HCA Healthcare has a 12 month low of $289.98 and a 12 month high of $417.14.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping analysts’ consensus estimates of $6.20 by $0.64. The company had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. The firm’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $5.50 earnings per share.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of HCA. GAMMA Investing LLC boosted its position in HCA Healthcare by 40,527.3% during the first quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company’s stock valued at $5,887,850,000 after purchasing an additional 1,699,713 shares during the last quarter. Nuveen LLC acquired a new stake in shares of HCA Healthcare in the first quarter valued at approximately $569,217,000. Pacer Advisors Inc. lifted its position in shares of HCA Healthcare by 6,237.9% in the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock valued at $466,815,000 after buying an additional 1,329,618 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of HCA Healthcare by 83.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after buying an additional 1,091,416 shares during the last quarter. Finally, Goldman Sachs Group Inc. lifted its position in shares of HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock valued at $615,583,000 after buying an additional 587,036 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the transaction, the chief operating officer directly owned 12,646 shares of the company’s stock, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be given a dividend of $0.72 per share. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.81%. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.